Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
Top Cited Papers
- 1 December 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 60 (6) , 1181-1188
- https://doi.org/10.1124/mol.60.6.1181
Abstract
The trace amine para-tyramine is structurally and functionally related to the amphetamines and the biogenic amine neurotransmitters. It is currently thought that the biological activities elicited by trace amines such as p-tyramine and the psychostimulant amphetamines are manifestations of their ability to inhibit the clearance of extracellular transmitter and/or stimulate the efflux of transmitter from intracellular stores. Here we report the discovery and pharmacological characterization of a rat G protein-coupled receptor that stimulates the production of cAMP when exposed to the trace amines p-tyramine, β-phenethylamine, tryptamine, and octopamine. An extensive pharmacological survey revealed that psychostimulant and hallucinogenic amphetamines, numerous ergoline derivatives, adrenergic ligands, and 3-methylated metabolites of the catecholamine neurotransmitters are also good agonists at the rat trace amine receptor 1 (rTAR1). These results suggest that the trace amines and catecholamine metabolites may serve as the endogenous ligands of a novel intercellular signaling system found widely throughout the vertebrate brain and periphery. Furthermore, the discovery that amphetamines, including 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”), are potent rTAR1 agonists suggests that the effects of these widely used drugs may be mediated in part by this receptor as well as their previously characterized targets, the neurotransmitter transporter proteins.Keywords
This publication has 32 references indexed in Scilit:
- Proceedings of the Australian Neuroscience Society Symposium: Schizophrenia MOLECULAR GENETICS OF SCHIZOPHRENIAClinical and Experimental Pharmacology and Physiology, 2001
- The Forgotten SerineJournal of Biological Chemistry, 2000
- Psychophysiological Aspects of Amphetamine-Methamphetamine AbuseThe Journal of Psychology, 1998
- Cloning of a Putative Human Neurotransmitter Receptor Expressed in Skeletal Muscle and BrainBiochemical and Biophysical Research Communications, 1998
- Amphetamine: Effects on Catecholamine Systems and BehaviorAnnual Review of Pharmacology and Toxicology, 1993
- Expression in animal cells of the 5‐HT1A receptor by a vaccinia virus vector systemFEBS Letters, 1992
- 2‐Phenylethylamine: A Modulator of Catecholamine Transmission in the Mammalian Central Nervous System?Journal of Neurochemistry, 1990
- The Monoamine Oxidase Inhibitor—Tyramine InteractionThe Journal of Clinical Pharmacology, 1989
- The pharmacology of Parkinson's disease: Basic aspects and recent advancesCellular and Molecular Life Sciences, 1984
- Biosynthesis and excretion of and tyramine in the ratLife Sciences, 1974